Thirty-nine healthcare executives, public health and policy leaders, some with former ties to the Centers for Medicare and Medicaid Services, the CMS Innovation Center and the Medicare Payment Advisory Commission, have submitted a joint letter to the Department of Health and Human Services strongly supporting proposed changes to Medicare Advantage payments.
The signers of the letter support CMS’s proposed changes in the Calendar Year 2024 Advance Notice with Proposed Payment Updates for the Medicare Advantage and Part D Prescription Drug Program, reports Healthcare Finance.
Insurers have objected to CMS’s proposed 1.03% increase that AHIP and Better Medicare Alliance contend is actually a more than 2% decrease.
The letter states, “These improvements are long overdue and badly needed to assure appropriate financial payments and stewardship for MA funds, fair payments to enable excellent care for sicker patients, sustainability of the overall Medicare program and security for all beneficiaries.”
